--- title: "Janus Living | 10-K: FY2025 Revenue: USD 24.84 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/282522983.md" datetime: "2026-04-13T10:05:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282522983.md) - [en](https://longbridge.com/en/news/282522983.md) - [zh-HK](https://longbridge.com/zh-HK/news/282522983.md) --- # Janus Living | 10-K: FY2025 Revenue: USD 24.84 M Revenue: As of FY2025, the actual value is USD 24.84 M. EPS: As of FY2025, the actual value is USD -5.91. EBIT: As of FY2025, the actual value is USD -18.98 M. ### Overall Company Performance (Continuing Operations) #### Revenue - Fiscal Year Ended December 27, 2025: $24,840 thousand - Fiscal Year Ended December 28, 2024: $11,887 thousand #### Cost of Revenue - Fiscal Year Ended December 27, 2025: $14,652 thousand - Fiscal Year Ended December 28, 2024: $6,238 thousand #### Gross Profit - Fiscal Year Ended December 27, 2025: $10,188 thousand - Fiscal Year Ended December 28, 2024: $5,649 thousand #### Selling, General and Administrative Expenses - Fiscal Year Ended December 27, 2025: $33,039 thousand - Fiscal Year Ended December 28, 2024: $12,572 thousand #### Operating Loss - Fiscal Year Ended December 27, 2025: -$22,851 thousand - Fiscal Year Ended December 28, 2024: -$6,923 thousand #### Interest Expense, Net - Fiscal Year Ended December 27, 2025: -$3,869 thousand - Fiscal Year Ended December 28, 2024: -$1,159 thousand #### Realized Gain on Exchange Transactions - Fiscal Year Ended December 27, 2025: $374 thousand - Fiscal Year Ended December 28, 2024: $1,019 thousand #### Unrealized Loss on Marketable Securities - Fiscal Year Ended December 27, 2025: -$0 thousand - Fiscal Year Ended December 28, 2024: -$1,238 thousand #### Unrealized Loss on Cryptocurrency Assets - Fiscal Year Ended December 27, 2025: -$402,054 thousand - Fiscal Year Ended December 28, 2024: -$0 thousand #### Unrealized Gain on Exchange Transactions - Fiscal Year Ended December 27, 2025: $768 thousand - Fiscal Year Ended December 28, 2024: $0 thousand #### Other Expense, Net - Fiscal Year Ended December 27, 2025: -$596 thousand - Fiscal Year Ended December 28, 2024: -$160 thousand #### Net Loss from Continuing Operations - Fiscal Year Ended December 27, 2025: -$341,486 thousand - Fiscal Year Ended December 28, 2024: -$8,301 thousand ### Discontinued Operations (Biotechnology Segment) #### Loss from Discontinued Operations - Fiscal Year Ended December 27, 2025: -$3,898 thousand - Fiscal Year Ended December 28, 2024: -$2,148 thousand #### Income Tax Benefit from Discontinued Operations - Fiscal Year Ended December 27, 2025: -$877 thousand - Fiscal Year Ended December 28, 2024: -$2,881 thousand #### Net (Loss) Income from Discontinued Operations - Fiscal Year Ended December 27, 2025: -$3,021 thousand - Fiscal Year Ended December 28, 2024: $733 thousand ### Total Company Performance #### Net Loss - Fiscal Year Ended December 27, 2025: -$344,507 thousand - Fiscal Year Ended December 28, 2024: -$7,568 thousand #### Adjusted EBITDA (Non-GAAP) - Total Fiscal Year Ended December 27, 2025: -$15,429 thousand - Total Fiscal Year Ended December 28, 2024: -$1,509 thousand - Fintech Segment (2025): -$2,611 thousand - Biotech (Discontinued Operations) Segment (2025): -$1,969 thousand - Corporate and Other Segment (2025): -$10,849 thousand ### Segment Performance #### Fintech Segment - Revenue (2025): $24,840 thousand - Cost of Revenue (2025): $14,652 thousand - Gross Profit (2025): $10,188 thousand - Gross Margin Percentage (2025): 41.0% - Operating Loss (2025): -$6,182 thousand - Revenue (2024): $11,887 thousand - Cost of Revenue (2024): $6,238 thousand - Gross Profit (2024): $5,649 thousand - Gross Margin Percentage (2024): 48.0% - Operating Income (2024): $193 thousand - Revenue increased by approximately $13.0 million in 2025 compared to 2024, primarily due to the acquisitions of ALT5 Subsidiary in May 2024 and Mswipe in May 2025. - Gross profit increased by approximately $4.6 million in 2025 compared to 2024, also due to the acquisitions. - Selling, general and administrative expenses for continuing operations increased by approximately $20.5 million in 2025 compared to 2024, mainly due to acquisitions, higher bad debt, legal expenses, and increased stock-based compensation. #### Biotechnology Segment (Discontinued Operations) - Operating Loss (2025): -$3,898 thousand - Operating Loss (2024): -$2,148 thousand - Selling, general and administrative expenses increased over the prior year due to increases in professional fees and research and development costs. #### Corporate and Other Segment - Revenue (2025 & 2024): $0 thousand - Operating Loss (2025): -$16,669 thousand - Operating Loss (2024): -$7,116 thousand - Selling, general and administrative expenses increased by approximately $9.6 million, primarily due to increased costs for stock-based compensation and legal expenses, as well as other professional services. ### Cash Flow #### Operating Activities - Fiscal Year Ended December 27, 2025: -$7,157 thousand (cash used) - Fiscal Year Ended December 28, 2024: $1,777 thousand (cash provided) - The decrease in cash from operations in 2025 was primarily due to the results of operations. #### Investing Activities - Fiscal Year Ended December 27, 2025: -$706,606 thousand (cash used) - Fiscal Year Ended December 28, 2024: $5,853 thousand (cash provided) - Cash used in investing activities in 2025 was primarily for the purchase of WLFI tokens, partially offset by tokens redeemed. #### Financing Activities - Fiscal Year Ended December 27, 2025: $716,797 thousand (cash provided) - Fiscal Year Ended December 28, 2024: $6,093 thousand (cash provided) - Cash provided by financing activities in 2025 primarily relates to proceeds from equity financing and issuance of notes payable, partially offset by fees for equity financing and payments on notes payable. ### Other Key Financial Metrics #### Cash and Cash Equivalents - As of December 27, 2025: $6,222 thousand - As of December 28, 2024: $7,177 thousand - Approximately $3.5 million of cash is fully reserved in connection with a legal matter as of December 27, 2025. #### Working Capital - As of December 27, 2025: -$21,900 thousand (net negative working capital), with total current assets of $29,466 thousand and total current liabilities of $51,399 thousand. #### Cryptocurrency Assets (WLFI tokens) - Fair Value as of December 27, 2025: $1,054,663 thousand - Units Held as of December 27, 2025: 7,283,585,650 WLFI tokens - Cost Basis as of December 27, 2025: $1,456,717,130 thousand - An unrealized loss of approximately -$402.1 million was recognized in 2025 related to the change in fair value of WLFI tokens. ### Outlook / Guidance Janus Living, Inc. plans to use proceeds from a $15.0 million draw-down to fund a share repurchase program, acquire additional WLFI tokens, and for general corporate purposes. The company intends to raise additional funds for its Biotechnology segment’s Phase IIb clinical trials and other strategic investments, with a potential plan to decouple the Biotechnology segment into a stand-alone entity while retaining a controlling interest. Management views its approximately 7.3 billion WLFI tokens, valued at $1.05 billion as of December 27, 2025, as a significant financial resource for liquidity, subject to market price risk, with a policy allowing sales for liquidity needs or material portfolio rebalancing events. ### Related Stocks - [JAN.US](https://longbridge.com/en/quote/JAN.US.md) ## Related News & Research - [Clas Ohlson climate targets win SBTi validation, commits to net-zero by 2045](https://longbridge.com/en/news/283099411.md) - [SemiLEDs Reports Second Quarter Fiscal Year 2026 Financial Results | LEDS Stock News](https://longbridge.com/en/news/282650581.md) - [14:12 ETINVESTOR NOTICE: Snowflake Inc. (SNOW) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit](https://longbridge.com/en/news/283040449.md) - [pferdewetten.de announces shareholder meeting in Düsseldorf](https://longbridge.com/en/news/283098051.md) - [Pineapple Financial Reports Fiscal Q2 2026 Financial Results and Provides Digital Asset Treasury Update | PAPL Stock News](https://longbridge.com/en/news/282587469.md)